Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

Clinical trial NCT00226954 · TERMINATED

Trial details

NCT number: NCT00226954
Sponsor: Stanford University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Urologic Neoplasms

Start date: 2003-03-01
Primary completion: 2007-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.